13D Filings
Home
FAQ
IO Biotech, Inc.
IOBT
Amendment
Ownership

27.40%

Total Shares

21,851,920

Issuer CIK

1865494

Event Date

Mar 30, 2026

Accepted

Jun 2, 2026, 04:07 PM

SEC EDGARView Original Filing
Reporting Persons (1)
NameType% of ClassAggregateSole VotingShared Voting
Lundbeckfond Invest A/S
CO
27.40%21,851,92021,851,9200
Disclosure Items (3)

Security Title

Common Stock, par value $0.001 per share

Issuer Name

IO Biotech, Inc.

Issuer Address

Ole Maaloes Vej 3, Copenhagen N, G7, DK-2200

Item 4 of the Statement is hereby amended and supplemented as follows: On March 31, 2026, the Issuer ceased operations and filed a voluntary petition for relief (the "Petition") under the provisions of Chapter 7 of Title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the District of Delaware. The assets of the Issuer will be liquidated and claims paid in accordance with the priorities specified in the Bankruptcy Code. Concurrently with the Petition, on March 31, 2026, each member of the Issuer's board of directors, including Christian Elling, resigned from the Board of Directors of the Issuer and all of its committees.

Percentage of Class

Rows 11 and 13 of the Reporting Person's cover page to this Schedule 13D/A set forth the aggregate number of shares of common stock and percentages of the shares of common stock beneficially owned by the Reporting Person and are incorporated by reference. The percentage set forth in each row 13 is based upon 71,948,842 shares of common stock outstanding as of November 10, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 14, 2025, and giving effect to Warrants, to the extent exercisable within 60 days hereof, as referenced herein. The Reporting Person directly holds 13,950,686 shares of common stock and 7,901,234 shares of common stock issuable upon exercise of Warrants. The board of directors of the Reporting Person, consisting of Steffen Kragh, Lars Holmqvist, Susanne Kruger Kjaer, Michael Kjaer, Peter Schutze, Gunhild Waldemar, Svend Andersen, Ludovic Tranholm Otterbein, Vagn Flink Moller Pedersen and Kristian Funding Andersen, and Lene Skole, the chief executive officer of the Reporting Person, may be deemed to share voting and investment authority over the shares held by the Reporting Person. No individual member of the board of directors of the Reporting Person is deemed to hold any beneficial ownership in the shares held by the Reporting Person.

Number of Shares

Rows 7 through 10 of the Reporting Person's cover page to this Schedule 13D/A set forth the number of shares of common stock as to which the Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition and are incorporated by reference.

Transactions

The Reporting Person has not effected any transaction with respect to the securities of the Issuer during the sixty days prior to the date of filing this Schedule 13D/A.

Shareholders

Under certain circumstances set forth in the governing documents of the Reporting Person, the stockholders of the Reporting Person may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the Issuer.

Date of 5% Ownership

Not applicable.